{
    "id": 5500,
    "name": "cellular ependymoma",
    "source": "DOID",
    "definition": null,
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:5500",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT01096368",
            "title": "Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma",
            "phase": "Phase III",
            "recruitment": "Active, not recruiting",
            "therapies": [
                {
                    "id": 8074,
                    "therapyName": "Carboplatin + Cyclophosphamide + Vincristine sulfate liposome",
                    "synonyms": null
                },
                {
                    "id": 8073,
                    "therapyName": "Carboplatin + Etoposide + Vincristine sulfate liposome",
                    "synonyms": null
                },
                {
                    "id": 8076,
                    "therapyName": "Cisplatin + Cyclophosphamide + Etoposide",
                    "synonyms": null
                },
                {
                    "id": 8075,
                    "therapyName": "Cisplatin + Cyclophosphamide + Etoposide + Vincristine sulfate liposome",
                    "synonyms": null
                }
            ]
        }
    ]
}